Novartis' Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera Post author:Sam Post published:January 25, 2018 Post category:BioPharma The drug is the first available FDA-approved Peptide Receptor Radionuclide Therapy. Source: BioSpace You Might Also Like Top 10 Life Science Job Trends in 2017 June 7, 2017 Guided Therapeutics Ships Five LuViva Advanced Cervical Scans To Chinese Partner April 12, 2017 Boston's resTORbio Sets Terms for $85M IPO January 16, 2018
